Agreement with Incotec Group

RNS Number : 1246L
Plant Health Care PLC
27 July 2011
 



27 July, 2011

 

Plant Health Care plc

 

PLANT HEALTH CARE ANNOUNCES LICENSING DEAL WITH INCOTEC

Plant Health Care (AIM: PHC), a leading provider of naturally derived products to the agriculture and horticulture industries, announces that it has signed a non-exclusive, multi-year agreement with INCOTEC Group BV ("INCOTEC") to develop and market Plant Health Care's Myconate in combination with INCOTEC's proprietary seed treatment packages. No financial details are disclosed.

 

Plant Health Care will contribute its Myconate technology and introduce its current customers to INCOTEC seed treatments. The two companies will work together to develop new and novel uses for Myconate around the world.

 

INCOTEC, based in The Netherlands, is one of the world's largest providers of seed treatments, technologies and services for vegetables, ornamentals and field crops.

 

The board of Plant Health Care believes this deal further validates the potential of Myconate to deliver yield increases and plant health benefits.

 

"This is an important breakthrough in our strategy to gain market penetration for Myconate" said John Brady, CEO of Plant Health Care. "INCOTEC is an excellent partner and a major player in seed treatment with a worldwide customer base, with whom we look forward to working closely."

 

Myconate is a patented, synthetic compound which encourages plant growth by stimulating existing mycorrhizal fungi in the soil and creating a bigger root mass. More than five years of successful field trials provide product efficacy with increased yields, during tests, of up to 30% depending upon crop and location. It is intended that Myconate will become a standard element of farmer's seeding and planting programmes on a global basis.

   

JanWillem Breukink, CEO of INCOTEC commented:  "We are very pleased with this cooperation as we believe Myconate is a very innovative product, that in combination with INCOTEC's products and technologies provides unique combinations to make plants stronger and to increase yields."

 

 

 

- ENDS -

 

 

 

 

 

 

 

 

 

 

 

 

For further information, please contact:

 

Plant Health Care plc 


John Brady, Chief Executive Officer


Tel: +1-603-525-3702


jabrady@planthealthcare.com


 

 

Evolution Securities

Tavistock Communications

Tim Redfern

Jeremy Carey/Simon Compton

Tel: +44-20-7071-4300

Tel: +44-20-7920-3150

tim.redfern@evosecuties.com

jcarey@tavistock.co.uk       

scompton@tavistock.co.uk 

 

 

 

About Plant Health Care plc: Plant Health Care plc ("PHC") is a leading provider of naturally derived products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, PHC currently has approximately 90 employees and has operations in the United States, Mexico, the United Kingdom, Spain and the Netherlands. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") in February 2010 (ticker symbol/ mnemonic: PHC).

 

PHC's products are aimed at the agriculture and landscape industries and are environmentally beneficial. Through the commercialisation of these products, PHC is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com.

 

About INCOTEC:

INCOTEC Group, with headquarters in the Netherlands, is worldwide leader in coating and seed technology serving the agronomic, vegetable and flower seed industry worldwide. Winner of the Erasmus Innovation Award 2009 INCOTEC activities are located in the USA, the Netherlands, Spain, Italy, Sweden, Brazil, Japan, India, Australia, China and South Africa. Further information is available at: www.incotec.com.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRQQLFLFDFXBBF
UK 100

Latest directors dealings